<DOC>
	<DOCNO>NCT00798109</DOCNO>
	<brief_summary>Schizophrenia severe mental illness lifetime morbidity risk close 1 % , involve genetic environmental risk factor . Prospective study show heavy use cannabis adolescence moderately increase risk develop schizophrenia . Many data also suggest co-occurrence cannabis abuse patient schizophrenia deleterious impact clinical outcome schizophrenia . Cannabis abuse schizophrenic patient significant public health problem empirically validate treatment . We presently study efficiency motivational therapy cannabis consumption patient schizophrenia .</brief_summary>
	<brief_title>Effect Motivational Therapy Schizophrenia With Cannabis Misuse</brief_title>
	<detailed_description>Schizophrenia severe mental illness lifetime morbidity risk close 1 % , involve genetic environmental risk factor . Prospective study show heavy use cannabis adolescence moderately increase risk develop schizophrenia . Many data also suggest co-occurrence cannabis abuse patient schizophrenia deleterious impact clinical outcome schizophrenia . Cannabis abuse schizophrenic patient significant public health problem empirically validate treatment . We presently study efficiency motivational therapy cannabis consumption patient schizophrenia . 330 patient schizophrenia cannabis abuse dependence ( accord DSM-IV criterion ) randomly assign 4 motivational interview one month usual intensive treatment . Treatment conduct outpatient evaluate inclusion 6 month Time-Line Follow Bach consumption , PANSS score , number relapseâ€¦ ) . A outcome measure urinalysis result provide objective measure cannabis use throughout six month trial .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>INCLUSION CRITERIA : Schizophrenia schizoaffective disorder accord DSMIV criterion Meeting DSMIV criterion actual cannabis abuse dependance current regular contact mental health service age interview 18 year No evidence organic brain disease clinically significant concurrent medical illness learn disability Written inform consent obtain subject ( patient parent ) . EXCLUSION CRITERIA : Not membership regime social security CMU</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Cannabis misuse comorbidity</keyword>
	<keyword>Motivational interview</keyword>
	<keyword>Randomised open trial</keyword>
</DOC>